Michael Newman - Oct 9, 2024 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
CSO and Director, Director, 10%+ Owner
Signature
/s/ Michael Newman
Stock symbol
INDP
Transactions as of
Oct 9, 2024
Transactions value $
$0
Form type
4
Date filed
10/10/2024, 04:05 PM
Previous filing
Jan 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (Right to Buy) Award $0 +75K $0.00 75K Oct 9, 2024 Common Stock 75K $1.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date.